Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 16 | 2025 | 11840 | 1.260 |
Why?
|
Stroke Volume | 14 | 2025 | 5596 | 0.710 |
Why?
|
Ventricular Function, Left | 9 | 2025 | 3928 | 0.640 |
Why?
|
Masks | 1 | 2020 | 209 | 0.580 |
Why?
|
Eligibility Determination | 1 | 2020 | 423 | 0.530 |
Why?
|
Prosthesis Implantation | 1 | 2020 | 595 | 0.500 |
Why?
|
Heart-Assist Devices | 3 | 2021 | 1296 | 0.490 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3413 | 0.480 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 560 | 0.470 |
Why?
|
Cardiology | 2 | 2021 | 1702 | 0.420 |
Why?
|
Infection Control | 1 | 2020 | 983 | 0.420 |
Why?
|
Selenium | 1 | 2016 | 419 | 0.410 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2020 | 1396 | 0.360 |
Why?
|
Cardiomyopathies | 1 | 2022 | 2067 | 0.340 |
Why?
|
Myocytes, Cardiac | 2 | 2016 | 1668 | 0.340 |
Why?
|
Medicaid | 2 | 2020 | 2833 | 0.330 |
Why?
|
Predictive Value of Tests | 1 | 2024 | 15398 | 0.290 |
Why?
|
Angiotensin Receptor Antagonists | 2 | 2024 | 1061 | 0.280 |
Why?
|
Health Personnel | 1 | 2020 | 3390 | 0.270 |
Why?
|
Prosthesis-Related Infections | 2 | 2021 | 496 | 0.250 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3100 | 0.250 |
Why?
|
Fibroblasts | 1 | 2016 | 4159 | 0.250 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3223 | 0.250 |
Why?
|
Sex Characteristics | 3 | 2023 | 2643 | 0.230 |
Why?
|
Myocardial Infarction | 2 | 2023 | 11499 | 0.230 |
Why?
|
Heart Transplantation | 1 | 2018 | 3310 | 0.230 |
Why?
|
Pandemics | 3 | 2021 | 8703 | 0.220 |
Why?
|
Telemedicine | 1 | 2021 | 3105 | 0.220 |
Why?
|
Naphthyridines | 1 | 2025 | 182 | 0.210 |
Why?
|
Ramipril | 1 | 2023 | 102 | 0.210 |
Why?
|
Glucagon-Like Peptides | 1 | 2024 | 157 | 0.200 |
Why?
|
Vascular Resistance | 1 | 2024 | 941 | 0.180 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2024 | 561 | 0.180 |
Why?
|
MicroRNAs | 1 | 2016 | 3785 | 0.170 |
Why?
|
Biphenyl Compounds | 1 | 2024 | 1019 | 0.160 |
Why?
|
Glomerular Filtration Rate | 2 | 2024 | 2233 | 0.150 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12240 | 0.150 |
Why?
|
Drug Combinations | 1 | 2024 | 2077 | 0.150 |
Why?
|
Coronary Circulation | 1 | 2024 | 1602 | 0.150 |
Why?
|
Cardiovascular Diseases | 2 | 2020 | 15652 | 0.150 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 248 | 0.140 |
Why?
|
Echocardiography | 3 | 2024 | 5045 | 0.140 |
Why?
|
Sodium | 1 | 2022 | 1591 | 0.140 |
Why?
|
Eicosapentaenoic Acid | 1 | 2020 | 565 | 0.130 |
Why?
|
Benzhydryl Compounds | 1 | 2022 | 939 | 0.130 |
Why?
|
Humans | 25 | 2025 | 765968 | 0.120 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2024 | 1339 | 0.120 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2016 | 220 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 747 | 0.120 |
Why?
|
Pre-Eclampsia | 1 | 2024 | 1261 | 0.110 |
Why?
|
SOXB1 Transcription Factors | 1 | 2016 | 282 | 0.110 |
Why?
|
Culture Media | 1 | 2016 | 890 | 0.110 |
Why?
|
Sex Factors | 3 | 2025 | 10603 | 0.110 |
Why?
|
Outpatients | 1 | 2021 | 1595 | 0.110 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2016 | 506 | 0.100 |
Why?
|
Medical Oncology | 1 | 2024 | 2339 | 0.100 |
Why?
|
Recovery of Function | 2 | 2020 | 2966 | 0.100 |
Why?
|
Risk Factors | 4 | 2024 | 74840 | 0.090 |
Why?
|
Income | 1 | 2020 | 1874 | 0.090 |
Why?
|
Male | 14 | 2025 | 363698 | 0.090 |
Why?
|
Risk Assessment | 2 | 2024 | 24282 | 0.090 |
Why?
|
Glucose | 1 | 2022 | 4335 | 0.090 |
Why?
|
Treatment Outcome | 8 | 2025 | 65188 | 0.090 |
Why?
|
Animals, Newborn | 1 | 2016 | 2669 | 0.090 |
Why?
|
RNA Interference | 2 | 2016 | 2832 | 0.090 |
Why?
|
Residence Characteristics | 1 | 2020 | 2116 | 0.080 |
Why?
|
Female | 13 | 2025 | 396112 | 0.080 |
Why?
|
Kidney | 1 | 2024 | 7066 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4562 | 0.080 |
Why?
|
Insurance Coverage | 1 | 2020 | 1944 | 0.080 |
Why?
|
Antioxidants | 1 | 2016 | 1670 | 0.070 |
Why?
|
Pulmonary Embolism | 1 | 2021 | 2598 | 0.070 |
Why?
|
Cell Differentiation | 2 | 2016 | 11641 | 0.070 |
Why?
|
Massachusetts | 1 | 2020 | 8875 | 0.070 |
Why?
|
Hospitals | 1 | 2020 | 3888 | 0.070 |
Why?
|
Double-Blind Method | 3 | 2025 | 12437 | 0.060 |
Why?
|
Hospitalization | 2 | 2023 | 10808 | 0.060 |
Why?
|
Aged | 8 | 2025 | 171117 | 0.060 |
Why?
|
Databases, Factual | 1 | 2020 | 8067 | 0.060 |
Why?
|
Middle Aged | 9 | 2025 | 223009 | 0.060 |
Why?
|
Mesenchymal Stem Cells | 1 | 2014 | 1663 | 0.050 |
Why?
|
Prognosis | 1 | 2024 | 29922 | 0.050 |
Why?
|
Benzylamines | 1 | 2024 | 251 | 0.050 |
Why?
|
Age Factors | 1 | 2020 | 18380 | 0.050 |
Why?
|
Gene Expression | 1 | 2016 | 7584 | 0.050 |
Why?
|
Uracil | 1 | 2024 | 210 | 0.050 |
Why?
|
Obesity | 1 | 2024 | 13076 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2024 | 59489 | 0.050 |
Why?
|
Neprilysin | 1 | 2024 | 484 | 0.050 |
Why?
|
Insulin | 1 | 2016 | 6599 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2014 | 4913 | 0.050 |
Why?
|
United States | 2 | 2020 | 72903 | 0.050 |
Why?
|
Time Factors | 2 | 2020 | 40065 | 0.040 |
Why?
|
Receptor, Angiotensin, Type 2 | 1 | 2020 | 61 | 0.040 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2024 | 345 | 0.040 |
Why?
|
Medicare | 1 | 2018 | 6823 | 0.040 |
Why?
|
Microvessels | 1 | 2024 | 591 | 0.040 |
Why?
|
Microcirculation | 1 | 2024 | 1280 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2014 | 10429 | 0.040 |
Why?
|
Chloroquine | 1 | 2020 | 276 | 0.040 |
Why?
|
Adenosine Monophosphate | 1 | 2020 | 231 | 0.040 |
Why?
|
Tetrazoles | 1 | 2024 | 920 | 0.040 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2020 | 127 | 0.040 |
Why?
|
Adult | 3 | 2024 | 223044 | 0.040 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 22332 | 0.040 |
Why?
|
Alanine | 1 | 2020 | 612 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2021 | 81514 | 0.040 |
Why?
|
Postpartum Period | 1 | 2024 | 1205 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2024 | 1272 | 0.030 |
Why?
|
Plasma | 1 | 2020 | 579 | 0.030 |
Why?
|
Virus Internalization | 1 | 2020 | 502 | 0.030 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 431 | 0.030 |
Why?
|
Neoplasms | 1 | 2024 | 22340 | 0.030 |
Why?
|
Syndrome | 1 | 2021 | 3271 | 0.030 |
Why?
|
Emergencies | 1 | 2021 | 1223 | 0.030 |
Why?
|
Aorta | 1 | 2021 | 2028 | 0.030 |
Why?
|
Young Adult | 1 | 2020 | 59889 | 0.030 |
Why?
|
Antimalarials | 1 | 2020 | 913 | 0.030 |
Why?
|
Coronary Vessels | 1 | 2024 | 3096 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2021 | 7478 | 0.020 |
Why?
|
Adolescent | 1 | 2020 | 88835 | 0.020 |
Why?
|
Patient Care Team | 1 | 2023 | 2517 | 0.020 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2024 | 2310 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2014 | 1202 | 0.020 |
Why?
|
Isoenzymes | 1 | 2014 | 1689 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 2014 | 1515 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8501 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 3050 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6547 | 0.020 |
Why?
|
Animals | 2 | 2016 | 168764 | 0.020 |
Why?
|
Transfection | 1 | 2014 | 5743 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2024 | 15880 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 2453 | 0.020 |
Why?
|
Regeneration | 1 | 2014 | 1517 | 0.020 |
Why?
|
Pregnancy | 1 | 2024 | 30260 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 13462 | 0.010 |
Why?
|
Prospective Studies | 1 | 2024 | 54802 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14448 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 18973 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41649 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18293 | 0.010 |
Why?
|
Signal Transduction | 1 | 2014 | 23601 | 0.010 |
Why?
|
Concepts
(142)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(53)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_